Fig 1: A, AVG microinjection under a rat left posterolateral thoracotomy. LCV indicates left cranial vein; LPV, left pulmonary vein; MPV, middle pulmonary vein. B, Expression of pGFP protein in rat cholinergic AVG neurons after in vivo lentiviral transfection of Cav2.2‐α shRNA with pGFP cDNA. C, Expression of Cav2.2‐α mRNA in DiI‐labeled AVG neurons from all groups of rats, measured by single‐cell real‐time RT‐PCR. N=20 neurons from 6 rats in each group. D, Expression of Cav2.2‐α protein in the AVG from all groups of rats, measured by reverse‐phase protein microarray. N=3 rats in each group. Data are means±SEM. Statistical significance in Figure 1C‐D was determined by 1‐way anova with post hoc Dunnett test against the sham group. *P<0.05 vs sham. AVG indicates atrioventricular ganglion; ChAT, choline acetyltransferase; pGFP, phosphorylated green fluorescent protein; RT‐PCR, reverse‐transcription polymerase chain reaction.
Fig 2: A, Representative signal of electrocardiographic recordings illustrating QT intervals and T‐peak to T‐end interval (Tpe) in sham and Cav2.2‐α shRNA transfected rats. B through F, Mean data for QT intervals, QTc intervals, QT dispersions (QTd), QTc dispersions (QTcd), and Tpe in all groups of conscious rats. Data are means±SEM; n=6 rats in each group. Statistical significance was determined by 1‐way ANOVA with post hoc Dunnett test against the sham group for comparison among multiple groups or by paired t test for comparison between before and after treatments, respectively. *P<0.05 vs sham; † P<0.05 vs before treatment.
Fig 3: Western blot image for expression of Cav2.2‐α protein in rat brain and gastrocnemius muscle with or without peptide antigen. Rat brain was used as Cav2.2‐α–positive tissue, and gastrocnemius muscle was used as Cav2.2‐α–negative tissue.
Supplier Page from OriGene Technologies for Cacna1b Rat shRNA Lentiviral Particle (Locus ID 257648)